LivaNova (LIVN) Free Cash Flow Growth (1y) (2017 - 2026)
LivaNova (LIVN) Free Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | -14.34% |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | -26.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.66% |
| Mar 31, 2026 | -63.91% |
| Dec 31, 2025 | -26.55% |
| Sep 30, 2025 | 89.29% |
| Jun 30, 2025 | 53.12% |
| Mar 31, 2025 | 267.74% |
| Dec 31, 2024 | 66.43% |
| Sep 30, 2024 | 248.77% |
| Jun 30, 2024 | 232.23% |
| Mar 31, 2024 | -72.59% |
| Dec 31, 2023 | 328.87% |
| Sep 30, 2023 | -68.18% |
| Jun 30, 2023 | -44.14% |
| Mar 31, 2023 | -36.57% |
| Dec 31, 2022 | -63.05% |
| Sep 30, 2022 | 43.11% |
| Jun 30, 2022 | -185.13% |
| Mar 31, 2022 | 83.02% |
| Dec 31, 2021 | -14.84% |
| Sep 30, 2021 | 1,228.31% |